EUVIMEDEUVIMED entdecken
Open Access

Growth Hormone Secretagogues as Potential Therapeutic Agents to Restore Growth Hormone Secretion in Older Subjects to Those Observed in Young Adults

Roy G Smith, Michael O Thorner

The Journals of Gerontology: Series A · 2023

DOI: 10.1093/gerona/glad022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology: Series A, 2023. Verfasst von Roy G Smith und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Scripps Research Institute, La Jolla, California, USA. Hauptthemen laut MEDLINE: Ghrelin, Human Growth Hormone. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of the growth hormone secretagogues (GHS) and the reverse pharmacology leading to the discovery of GHS receptor which enabled the identification of ghrelin as the natural ligand for the receptor have opened a new horizon in growth hormone (GH) physiology, pathophysiology, and therapeutics. Major progress has been made and we now have orally active GHS which are able to restore optimal pulsatile GH secretion which cannot be overstimulated as insulin-like growth factor feedback regulates the peaks to the optimum level. This enables GH to be restored in the older to levels normally seen in 20- to 30-year-old people; this leads to an increase in fat-free mass and redistribution of fat to the limbs. As these agents are ultimately approved and investigated further, it is likely that they will be shown to restore growth in children with moderate-to-mild GH deficiency; their benefits will be investigated in other indications such as nonalcoholic fatty liver disease, frailty, anemia, osteoporosis, and immune compromise in older subjects. The exquisite regulation of GH secretion reflects the importance of GH pulsatility in the regulation of somatotroph action of GH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GhrelinHuman Growth HormoneAgedHumansGrowth HormoneGrowth Hormone-Releasing HormoneSecretagoguesYoung Adult

Stichwörter der Autor:innen

Functional limitationGrowth hormone secretagoguesMobility disabilitySarcopeniaSkeletal muscle dysfunction

Substanzen

GhrelinGrowth HormoneGrowth Hormone-Releasing HormoneHuman Growth HormoneSecretagogues

Autor:innen und Institutionen

  • Department of Molecular Medicine, Scripps Research Institute, La Jolla, California, USA.
  • Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Lumos Pharma, Austin, Texas, USA.

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institute on Aging
  • National Institutes of Health

Zitieren

APA

Smith, R. G., & Thorner, M. O. (2023). Growth Hormone Secretagogues as Potential Therapeutic Agents to Restore Growth Hormone Secretion in Older Subjects to Those Observed in Young Adults. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glad022

Vancouver

Smith RG, Thorner MO. Growth Hormone Secretagogues as Potential Therapeutic Agents to Restore Growth Hormone Secretion in Older Subjects to Those Observed in Young Adults. The Journals of Gerontology: Series A. 2023. doi:10.1093/gerona/glad022

BibTeX
@article{Smith2023,
  author = {Smith, Roy G and Thorner, Michael O},
  title = {Growth Hormone Secretagogues as Potential Therapeutic Agents to Restore Growth Hormone Secretion in Older Subjects to Those Observed in Young Adults},
  journal = {The Journals of Gerontology: Series A},
  year = {2023},
  doi = {10.1093/gerona/glad022}
}
Kostenlos starten →